These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34588212)
1. Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology. Fitzgerald I; O'Connell J; Keating D; Hynes C; McWilliams S; Crowley EK Evid Based Ment Health; 2022 Feb; 25(1):15-22. PubMed ID: 34588212 [TBL] [Abstract][Full Text] [Related]
2. [Prevention and treatment of antipsychotic induced weight gain]. Veerman SRT; Cohen D Tijdschr Psychiatr; 2023; 65(4):259-265. PubMed ID: 37323046 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
5. Predicting antipsychotic-induced weight gain in first episode psychosis - A field-wide systematic review and meta-analysis of non-genetic prognostic factors. Fitzgerald I; Sahm LJ; Byrne A; O'Connell J; Ensor J; Ní Dhubhlaing C; O'Dwyer S; Crowley EK Eur Psychiatry; 2023 Jun; 66(1):e42. PubMed ID: 37278237 [TBL] [Abstract][Full Text] [Related]
6. Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial. de Boer N; Guloksuz S; van Baal C; Willebrands L; Deenik J; Vinkers CH; Rossum IW; Zinkstok J; Wilting I; Zantvoord JB; Backx F; Swildens WE; Schouw M; Bogers J; Hulshof F; de Knijff R; Duindam P; Veereschild M; Bak M; Frederix G; de Haan L; van Os J; Cahn W; Luykx JJ BMC Psychiatry; 2021 Jan; 21(1):4. PubMed ID: 33402159 [TBL] [Abstract][Full Text] [Related]
8. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies. Bushe CJ; Bradley AJ; Doshi S; Karagianis J Int J Clin Pract; 2009 Dec; 63(12):1743-61. PubMed ID: 19840151 [TBL] [Abstract][Full Text] [Related]
9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations. Stogios N; Humber B; Agarwal SM; Hahn M Curr Psychiatry Rep; 2023 Nov; 25(11):707-721. PubMed ID: 37755655 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis. Hegde NC; Mishra A; Maiti R; Mishra BR; Mohapatra D; Srinivasan A Gen Hosp Psychiatry; 2024; 90():12-21. PubMed ID: 38878592 [TBL] [Abstract][Full Text] [Related]
12. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. Cooper SJ; Reynolds GP; ; Barnes T; England E; Haddad PM; Heald A; Holt R; Lingford-Hughes A; Osborn D; McGowan O; Patel MX; Paton C; Reid P; Shiers D; Smith J J Psychopharmacol; 2016 Aug; 30(8):717-48. PubMed ID: 27147592 [TBL] [Abstract][Full Text] [Related]
14. Informing the development of antipsychotic-induced weight gain management guidance: patient experiences and preferences - qualitative descriptive study. Fitzgerald I; Crowley EK; Ní Dhubhlaing C; O'Dwyer S; Sahm LJ BJPsych Open; 2024 Aug; 10(5):e136. PubMed ID: 39086041 [TBL] [Abstract][Full Text] [Related]
15. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. Lee K; Abraham S; Cleaver R Gen Hosp Psychiatry; 2022; 78():58-67. PubMed ID: 35863294 [TBL] [Abstract][Full Text] [Related]
16. Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk. Smith C; Myles H; Galletly C Australas Psychiatry; 2017 Aug; 25(4):387-390. PubMed ID: 28747113 [TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D; Gillen E; Rixson L JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353 [TBL] [Abstract][Full Text] [Related]
19. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ; Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227 [TBL] [Abstract][Full Text] [Related]
20. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy. Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]